Última Hora: "Governo PS e os apoios à Raríssimas. Valor manteve-se, não quadruplicou - Observador" Thu, 14 Dec 2017 12:11:41 GMT   "This RSS feed URL is deprecated" Thu, 14 Dec 2017 21:19:39 GMT    "Estados Unidos aprovam fim da neutralidade da internet - RTP" Thu, 14 Dec 2017 20:31:00 GMT    "SEF abre concurso para admitir 100 inspetores - Diário de Notícias - Lisboa" Thu, 14 Dec 2017 15:04:00 GMT    "Novo modelo da Autoeuropa faz disparar produção automóvel em Portugal - Expresso" Thu, 14 Dec 2017 16:56:00 GMT    "Anacom está analisar alterar condições do serviço postal - Jornal de Negócios - Portugal" Thu, 14 Dec 2017 18:29:00 GMT    "Nuno Mota Pinto vai presidir ao Montepio e os restantes administradores deverão sair com Félix Morgado - Expresso" Thu, 14 Dec 2017 20:28:00 GMT    "BES: Tribunal declara nula acusação de BdP contra Salgado e Amílcar Pires - Público.pt" Thu, 14 Dec 2017 21:16:11 GMT    "Raríssimas: Jerónimo de Sousa acredita que a "procissão ainda vai no adro" - Diário de Notícias - Lisboa" Thu, 14 Dec 2017 19:33:09 GMT    "Uber cobra 12 mil euros por viagem de 20 minutos - Dinheiro Vivo" Thu, 14 Dec 2017 18:18:43 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de Sepracor Inc.

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »

An Overview of Obsessive-Compulsive Disorder and Related Conditions: November 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Directorate Change
London South East (blog)
... a member of the Board, at Vectura Group plc. Prior to this, he served as Chief Executive Officer and Chief Operating Officer at Critical Therapeutics Inc. and has also held senior management positions at Sepracor, Inc. (now Sunovion Pharmaceuticals ...


Pulmatrix (PULM) Appoints Dr. James Roach as CMO
StreetInsider.com
Pulmatrix, Inc. (NASDAQ: PULM), today announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer, effective November 3, 2017. Dr. Roach will lead the clinical development of Pulmatrix's innovative inhaled drugs ...

e mais »

Zacks Small Cap Research (press release)

PULM: Business And Financial Update For Third Quarter 2017
Zacks Small Cap Research (press release)
Prior to joining Veristat, he served as Senior Vice President, Development and Chief Medical Officer of Momenta Pharmaceuticals, Senior Vice President, Medical Affairs at Sepracor Pharmaceuticals, and Head of Medical Affairs at Millennium ...


Flex Pharma Reports Third Quarter 2017 Financial Results
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity associated with severe neurological diseases such as ...

e mais »

Newsient (blog)

United States Desloratadine Market Report 2017 | Qualitative Analysis
Newsient (blog)
... price, revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Teva Wante Pharmaceutical Novartis India Limited Mylan Sepracor Sandoz Apollo Pharmaceuticals GSK Mayne Pharma Inc Abhilasha Pharma Pvt ...

e mais »

Newshawk Time

Asthma Medication Market 2017: Global Industry Analysis, Top Company, Research Forecast, Analysis and Supply ...
Newshawk Time
Asthma Medication Market Segment by Manufacturers: ? Dulera,QVAR,Glaxosmithkline plc,MAP Pharmaceuticals?Inc,Merck & Co. Inc,AstraZeneca plc,Roche Holdings Ltd,Genentech Inc,Sepracor, Inc,Schering-Plough Corp,Sanofi-Aventis,Theravance Inc ...

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
From 2007-2010, Mr. Koven served as Executive Vice President, General Counsel and Corporate Secretary at Sepracor Inc., where he was responsible for the company's legal and government affairs departments and Corporate Secretarial function until its ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
Prior to HeartWare, Ms. Trevvett served in communications and investor relations roles at both Alkermes, Inc., a global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases, and Sepracor, ...

e mais »

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Desloratadine Sales Market Synthesis Healthcare, Clinical Reviews Reports 2017 to 2022
Equity Insider (press release)
These stakeholders include: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, ...

e mais »

Form 8-K Acer Therapeutics Inc. For: Oct 02
StreetInsider.com
CAMBRIDGE, MA ? October 5, 2017 Acer Therapeutics Inc., (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters